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Abstract
The ‘‘two-signal paradigm’’ in T cell activation predicts that the cooperation of ‘‘signal 1,’’ provided by the T cell receptor
(TCR) through engagement of major histocompatility complex (MHC)-presented peptide, with ‘‘signal 20 provided by
costimulatory molecules, the prototype of which is CD28, is required to induce T cell effector functions. While the individual
signalling pathways are well understood, little is known about global changes in the proteome pattern during TCR/CD28-
mediated activation. Therefore, comparative 2-DE-based proteome analyses of CD3
+ CD69
- resting T cells versus cells
incubated with (i) the agonistic anti-CD3 antibody OKT3 mimicking signal 1 in absence or presence of IL-2 and/or with (ii)
the agonistic antibody 15E8 triggering CD28-mediated signaling were performed. Differentially regulated spots were
defined leading to the identification of proteins involved in the regulation of the metabolism, shaping and maintenance of
the cytoskeleton and signal transduction. Representative members of the differentially expressed protein families, such as
calmodulin (CALM), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), L-lactate dehydrogenase (LDH), Rho GDP-
dissociation inhibitor 2 (GDIR2), and platelet basic protein (CXCL7), were independently verified by flow cytometry. Data
provide a detailed map of individual protein alterations at the global proteome level in response to TCR/CD28-mediated T
cell activation.
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Introduction
Activation and expansion of antigen-specific T cells are essential
prerequisites for the successful mounting of specific immune
responses, both at the cellular as well as the humoral level. The
discovery of costimulatory molecules which act in concert with the
TCR-mediated signals led to the ‘‘two signal paradigm’’ that naı ¨ve
T cells require at least two activation signals, one by the TCR and
the other by costimulatory molecules in order to initiate full T cell
activation [1,2,3,4]. Intensive research performed in this field over
the last two decades has provided deep insights into the
requirements and underlying mechanisms leading to the activation
or inactivation of effector, memory and regulatory T cell subsets
[1]. Engagement of the TCR with the peptide loaded MHC on the
cell surface of the antigen presenting cell (APC) provides signal 1.
The second signal is mediated by activating members of the
costimulatory CD28 family [3,4]. The CD28 ligand family of B7
molecules like B7-1 (CD80) and B7-2 (CD86), also expressed on
activated APCs, promote proliferation, survival and differentiation
of T cells into distinct T cell subsets [5,6]. Lack of costimulatory
signals causes T cell anergy [7,8] while engagement of B7-1 or PD-
L1 (B7-H1, CD274) and PD-L2 (B7-DC, CD273) with the
inhibitory receptors CTLA-4 (CD152) or PD1 (CD279), respec-
tively, induce T cell unresponsiveness and tolerance [5].
With respect to the profound impact on T cell function the
downstream signaling cascades of the B7/CD28 pathway were
further investigated in detail. While for the priming of CD4
+
T cells the B7-1/B7-2-CD28 interaction is not always required
[9], it is essential for primary and memory CD8
+ T cell responses
[4,10,11,12]. CD28 not only provides T cell costimulation but also
enhances the phosphoinositide 3-kinase (PI3K)/serine/threonine
protein kinase (AKT) activity, which is dependent on the p110
delta isoform of PI3K at the immunological synapse [13]. The
enhanced T cell APC interaction is supported by B7-1 dimers
which is associated with the sustained accumulation of signaling
molecules within TCR-CD28 microclusters [14,15,16]. In adition,
a strong CD28-mediated co-stimulatory signal is necessary to
induce proliferation of CD4
+CD25
+ regulatory T cells, which can
not be substituted by IL-2 [17]. Moreover, microRNAs are
involved in the control of T cell activation due to their
costimulation dependent expression down-regulating the negative
regulator phosphatase and tensin homolog (PTEN) [18]. CD28
costimulation has also a strong impact on T cell survival as
demonstrated by an enhanced expression of the anti-apoptotic
molecule B cell lymphoma –extra large (Bcl-xL) [19]. In addition
Ca
2+signaling-mediated activation of intracellular pathways are
involved in costimulation via CD86 and CD28 interaction [20].
The clinical significance of these pathways became obvious in the
response to superagonistic CD28-antibodies triggering the induc-
tion of harmful pro-inflammatory cytokine storms [21]. In
contrast, the modulation of the CD28-mediated costimulation
cascade or the inhibition of its inhibory receptor cytotoxic T-
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of auto-immunity, transplant rejections and tumors
[6,22,23,24,25,26]. In addition, CD28 costimulation can be used
to amplify tumor-specific T cells [27] or to drive expansion of
chimeric antigen receptor (CAR)-engineered T cells with redirect-
ed specificity [28]. Both strategies provide attractive options in the
adoptive immunotherapy of cancer.
Despite increasing knowledge of the costimulatory pathways at
the molecular level little is known about the impact of
costimulation on the global protein expression pattern of T cells.
Previous proteome studies [29,30,31,32,33] predominantely
focused on quantitave changes of the phospho-proteome by
applying metabolic labelings via stable isotope labeling of amino
acids in cell culture (SILAC) or by stable-isotope iTRAQ labelings.
However, these studies mainly used ‘‘bottom up’’-proteomics
approaches that are not able to distinguish between different
protein isoforms. For instance the LC-MS approach for the
analysis of components of the TCR/MHC peptide complex in
murine T cells [34] or a phosphotyrosine proteomic profiling
resulting in the identification of a new interaction partner of the
TCR signalosome [29]. In addition peptide pull-down assays of
phosphorylated adapter proteins and network analysis showed
phosphorylation-dependent changes of protein-protein interac-
tions in T lymphocytes [31,32]. In contrast, less is known about the
effects in T cells resulting upon the concerted TCR/CD28-
mediated activation process [35,36]. The impact of phytohaem-
agglutinin (PHA)-mediated activation on the global proteome [37]
does not reflect the effects of TCR or costimulation-mediated T
cell activation.
In this study a series of two-dimensional gel electrophoresis (2-
DE)-based proteomic expression profilings were derived from
highly purified human CD3
+ T cells of healthy donors upon TCR,
CD28 and combined TCR/CD28 stimulation. To thoroughly
control T cell activation T cells were stimulated with agonistic
antibodies mimicking TCR activation (OKT3) or CD28 triggering
(15E8). Data were compared to TCR stimualion in presence of IL-
2 that like CD28 provides anti-apoptotic, proliferative signals to
pre-activated T cells. Extensive profiling led to the identification of
a set of differentially expressed proteins that could be classified
according to their function and cellular localization. Using this
strategy global alterations in the T cell proteome were defined that
can be discriminated with respect to TCR stimulation or CD28
costimulation only or to combined TCR/CD28 stimulation as well
as IL-2 supplementation. Identified differentially expressed
proteins are potential markers to assess the activation status of
human T cells.
Results
The Mode of T Cell Activation Induces Characteristic
Alterations in the Protein Expression Pattern
For proteomic profiling resting CD3
+ CD69
2 T cells were
isolated to a purity of .98% by negative selection to avoid pre-
stimulation (Figure 1).
Such purified T cells were either stimulated via the CD3, CD3
plus IL-2, CD28 or CD3 plus CD28 complex/receptors,
respectively or by incubation with the respective agonistic
antibodies, while isotype-matched antibodies served as controls.
Cells were subjected to 2-DE-based proteome analyses using silver
staining and/or the difference gel electrophoresis (DIGE)
approach. For the latter applying a minimal labelling strategy.
The 2-DE patterns found by the classical 2-DE and the DIGE
technologies were similar indicating the validity of both procedures
in proteome analysis. Different ways of T cell stimulation induce
different patterns in the protein expression profile as representa-
tively shown in Figure 2. Using silver stained gels 783 to 1063 spots
per gel were recorded whereas minimal DIGE labellings resulted
in the detection of 976 spots as summarized in Table 1.
Based on the 2-DE gel analyses 97 differentially expressed spots
were identified, matched to the profile of preparative gels and
analysed by mass spectrometric analysis. Fiftytwo protein identities
were identified in these spots. As summarized in Table S1, the
profiling based on the silver stainings led to the identification of 47
differentially expressed spots. Nineteen thereof were up- and 28
spots were downregulated under different stimuation conditions.
However, 8 spots contained more than one protein restricting the
subset of differentially expressed proteins to 39 single target spots,
representing a total number of 33 distinct protein identities (Table
S2). Some proteins including glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH), enolase alpha (ENOA) or vinculin (VINC) as
well as beta-/gamma-actin (ACTB/ACTG) were detected in more
than one spot suggesting that these proteins have undergone post-
translational modifications.
DIGE-based profiling revealed 56 spots with increased and 75
spots with decreased expression levels in response to different
stimulation conditions (Table S3). Thirty-four of the 56 up-
regulated spots represent single target spots whereas the remaining
22 spots contained more than 1 protein species. Some of the 34
single target spots representing a total number of 20 protein
identities were co-regulated under the individual stimulatory
signals. Of the 75 spots defined as down-regulated in response to
the various stimulation conditions, 55 were single target spots
representing 24 different proteins (Table S3).
Again some of the differentially expressed proteins defined by
this profiling strategy were represented by more than one spot
identity indicating again the presence of post-translational
modifications. These proteins included the protein disulfide-
isomerase A3 (PDIA3), fructose-bisphosphate aldolase A (AL-
DOA) and VINC. Thus, the DIGE-based profiling pattern is in
accordance to the pattern observed in silver stained gels.
Figure 1. Purity of resting CD3
+ T cell population. CD3
+ T cells
were isolated from peripheral blood by negative selection procedures
using magnetic cell separation techniques. Cells were analyzed by flow
cytometry using an anti-CD3 and anti-CD69 antibody. A dot plot from
one representative separation is shown.
doi:10.1371/journal.pone.0032994.g001
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partially counter-regulated under the various stimulation condi-
tions (Table S2), a total of 37 differentially expressed proteins were
identified by DIGE.
Briefly summarized, 18 of the differentially expressed proteins
were defined by both profiling strategies. 15 exclusively defined by
silver staining and 19 exclusively by DIGE (Table S1, Table S2 and
TableS3).Proteinsdefinedbybothtechniquesincludeactin-related
protein2/3complexsubunit2(ARPC2),alpha-actinin-1(ACTN1),
ENOA, ATP synthase subunit beta, mitochondrial (ATPB),
calreticulin (CALR), ALDOA, gelsolin (GELS), heat shock cognate
71 kDa protein (HSP7C), integrin-linked protein kinase (ILK),
lactate dehydrogenase beta chain (LDHB), manganese superoxide
dismutase (SODM), CXCL7, profilin-1 (PROF1), PDIA3, protea-
some subunit beta type 4 (PSB4), serum albumin (ALBU),
thioredoxin 1 (THIO), tubulin beta-2 chain (TBB5) and VINC.
Thecombinedprofilingdataforthetotalnumberof52differentially
expressed protein identities are summarized in Figure 3 (Table S4).
Figure 2. Representative protein expression profiles of T cells in response to distinct stimuli. Unstimulated (PBS) or stimulated T cells
were, extracted and subsequently separated by two-dimensional gel electrophoresis in 16% T, 2.5% C polyacrylamide gels as outlined in Materials
and Methods. The upper panel shows protein expression profiles obtained by separation of 150 mg total protein and visualized by silver staining, the
lower panel the corresponding DIGE labelings established by separating 15 mg minimal labeled total lysate per individual sample. The stimulation
procedures, the pH-gradient used in the first dimension as well as the range of the size fractionation are indicated along the axis.
doi:10.1371/journal.pone.0032994.g002
Table 1. Summary of the protein expression profiling results using different staining strategies.
silver staining
sample CD3 vs. PBS CD28 vs. PBS CD3/CD28 vs. PBS
total no. of spots 783 954 797 954 1063 954
no. of matched spots 584 581 649
no. of upreg. spots 68 67 89
no. of downreg. spots 72 74 93
no. of not reg. spots 444 440 467
DIGE
Sample CD3 vs. PBS CD3/IL2 vs. PBS CD28 vs. PBS CD3/CD28 vs. PBS
total no. of spots 976 976 976 976
no. of matched spots 976 976 976 976
no. of upreg. Spots 31 76 98 77
no. of downreg.spots 149 206 148 96
no. of not reg. spots 796 694 730 801
Upper panel : analysed with Proteomweaver 4.O (Biorad, Mu ¨nchen, Germany).
Lower panel: analysed with Delta 2D (Decodon, Greifswald, Germany).
doi:10.1371/journal.pone.0032994.t001
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Based on current gene ontology information the 52 differentially
expressed proteins represented in single target spots were classified
according to their cellular function, the cellular process they are
involved in and their cellular localization. The clustering
according to the cellular function was restricted to a subset of
18 gene ontology (GO)-annotated functions that might have an
impact during T cell activation (Figure 4). Similarly, 13 cellular
processes and 8 distinct cellular compartments likely involved in
this process were selected. Moreover, the clustering was not
restricted to a single feature, therefore the majority of the
differentially expressed proteins could be linked to several cellular
functions, various processes or different cellular compartments.
The most dominant cellular function is protein binding assigned
to 39/52 differentially expressed proteins, followed by 17 proteins
exerting catalytic activity, 14 each representing binders of
cytoskeletal proteins or metal ions, respectively, 10 binding
nucleotides and 9 binding to receptors. Less frequently represented
are proteins displaying transporter or transferase activity (5) or
proteins binding DNA, with structural molecule activity or binding
sugars, (4). Seven of the selected functions, including Rho GDI
activity, mRNA binding, signal transducer activity, receptor
activity, growth factor activity and transcription repressor activity
are only rarely represented (Figure 3). Moreover, several of the
identified proteins are linked to multiple functions, in particular
CALR, UDP-glucose pyrophosphorylase 2 (UGPA), transketolase
(TKL), CXCL7, phosphoglycerate kinase 1 (PGK1), ENOA,
transaldolase (TALDO), ACTN1, talin (TLN1) and myosin 9
(MYH9) (Figure 4).
Figure 3. Combined profiling data for the 52 differentially expressed proteins. The venn diagramm shows the distribution of individually
and shared proteins as defined by 2-DE-based proteomic profilings in response to the indicated stimulation conditions. Proteins that are either
shared in response to CD3 and CD28 or CD3/IL2 and CD3/CD28 are listed next to the connecting lines. Proteins defined via silver staining are listed in
plain, proteins defined by DIGE-analysis in bold. The relative regulation mode for the given protein if compared to its expression level in unstimulated
T cells is indicated by arrows. Arrows pointing up indicate increased expression levels in response to stimulation, whereas downregulated proteins
after flanked by arrows pointing down.
doi:10.1371/journal.pone.0032994.g003
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of 52 differentially expressed proteins are associated with
metabolic processes, 15 with transport, 7 with cytoskeleton
organization and 6 with signal transduction processes. In contrast,
proteins involved in the establishment or maintenance of cell
polarity, positive regulation of cell division, focal adhesion
assembly, regulation of cell shape, regulation of growth, cell
adhesion, direct with T cell activation, cytokinesis and exocytosis
were rarely detected (Figure 4). Again a number of the identified
proteins are linked to several cellular processes, such as TALDO
and MYH9 to 3 distinct categories and 13 at least to 2, including
CXCL7, GAPDH, LDHB, GDIR2 and others.
Figure 4. Classification of the differentially expressed proteins according to their cellular function, cellular process and their
cellular localization. The graphs display the results following the classification of the subset of differentially expressed proteins represented in
single target spots identified via peptide mass fingerprinting according to 18 selected cellular functions (left panel), 13 selected cellular processes
(middle panel) and 8 cellular localizations (right panel) along with the respective GO annotation codes. Proteins which could not be assigned to any
of these selected processes were classified as ‘‘other’’. The total number of proteins identified is 52. The 1
st and 2
nd columns indicate the profiling
strategy. The 3
rd and 4
th columns provide the individual UniProtKB and the protein ID’s. The numbers along the x-axis indicate the number of targets
grouped under the given GO annotation code, whereas the numbers on the y-axis the number of shared characteristics or compartments,
respectively.
doi:10.1371/journal.pone.0032994.g004
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differentially expressed proteins are assigned to the cytosol, 19 to
the cytoskeleton, 18 to the membrane, 14 to the extracellular
region and 11 to the nucleus. Less proteins were derived from
mitochondria, the endoplasmic reticulum (ER) and the Golgi
apparatus, at numbers of 5 to 4 to 2, respectively (Figure 4).
ACTN1 can be assigned to 5 compartments, VINC, THIO and F-
actin capping protein alpha-2 (CAZA2) to 4 and a panel of
9 proteins, including ARPC2, GELS, ENOA, protein disulfide
isomerase A1 (PDIA1), plastin (PLSL), Rho GDI dissociation
inhibitor 1 (GDIR1), actin-like protein 3 (ARP3) and TLN1 to
3 distinct compartments (Figure 4).
Verification of Differentially Expressed Proteins by Flow
Cytometry
Since the majority of the differentially expressed proteins in
response to the distinct stimulation conditions was involved in
metabolic processes, the reorganisation of the cytoskeleton and
signal transduction pathways, the expression pattern of represen-
tative members of these cellular processess were independently
assessed by flow cytometric analyses. The panel of verified proteins
is comprised of CALM, a component of the cytoskeleton and
regulator of cytokinesis; Rho GDP-dissociation inhibitor 2
(GDIR2), a member of G-protein signaling pathways; CXCL7,
which stimulates DNA synthesis, mitosis and glycolysis; and the
glycolytic enzymes LDH and GAPDH. Moreover, the expression
level of linker for activation of T cells family member 1 (LAT) as
an indicator for effective TCR stimulation was also determined by
flow cytometry (Figure 5). CD3/CD28 co-stimulation led to the
highest LAT expression levels followed by CD3 plus IL2
stimulation whereas stimulation via CD3 or CD28 alone
expectedly resulted in low LAT expression. Concomitantly,
CALM was highly expressed, which is in accordance to the fact
that full T cell activation is calcium dependent and accompanied
by a reorganization of the cytoskeleton. In contrast, GDIR2
expression is down-regulated under all costimulatory conditions.
Glycolytic enzymes, however, are differentially expressed in
response to different stimulation modes. The highest LDH
expression levels were detected in CD3/CD28-stimulated T cells,
whereas CD3/IL2 or partial activation via CD3 or CD28 led to a
less pronounced LDH induction. All costimulatory conditions
induced the glycolytic pathway. GAPDH, however, was highly
expressed in response to CD3/IL-2 stimulation whereas the other
costimulation modes induced lower GAPDH levels. This is also
the case for the expression of CXCL7, revealing an expression
pattern similar to GAPDH. The observed protein regulation
pattern is stable as shown by Figure 6, representing bar graphs for
the profiling results of 5 independent biological replicates.
Discussion
The expression profiling of T cells in response to defined stimuli
by gel-based 2-DE using two different protein staining strategies
revealed a defined subset of differentially regulated genes. Whereas
both protocols revealed roughly the same number of differentially
regulated spots there were some differences. DIGE-based profil-
ings revealed more down- and non-regulated spots than silver
stainings, although both procedures showed nearly the same
numbers of up-regulated proteins (Table 1). The increased
number of none regulated spots may likely be attributed to
differences in the matching concepts of the imaging software,
which for the Delta2D software package (DIGE-based profiling)
relies on a 100 percent matching strategy, but for the
Proteomweaver software (silver staining-based profiling) on a
further distinction between matched and unique spots for the
expression profile comparison.
However, the profiling results provide novel insights into the
changes occuring in response to distinct activation signals at the
protein expression level in T cells, independent of the used staining
strategy. Noteworthy the panels of differentially expressed proteins
defined by both strategies represent proteins with similar functions,
involved in similar processes and frequently represented in more
than one cellular compartment (Figure 4). The key celluar
processes delineated from the panel of differentially expressed
proteins are consistent with known T cell activation-related
processes. Thus, the activation of signal transduction pathways,
the induction and maintenance of complex metabolic processes,
the transport of cellular components into different cellular
compartments and along the cytoskeletal backbone, or the
reorganization of the cytoskeleton fully support the activation
process and its subsequent initiation of cell divisions. The
operation of these processes involves 2 to 5 cellular compartments,
a feature shared by the majority of the defined differentially
expressed proteins (Figure 4).
In general the profiling data resulted in both the description of
novel targets, but also the confirmation of previously reported
findings. The characterization of the plasma membrane-proximal
T cell activation responses in Jurkat T cells led to the identification
of a complex protein network that is anchored in the vicinity of
activated TCR [38]. Highly enriched in the membrane domains of
activated T cells are proteins involved in early signaling events
including the tyrosine kinase zeta-chain-associated protein kinase
70 (ZAP-70), which is recruited to CD3 subunits of the TCR in
response to the phosphorylation of tyrosine-based activation motifs
by kinases (Lck and Fyn). ZAP-70 subsequently phosphorylates
LAT leading to the recruitment of the adaptor proteins growth
factor receptor-bound protein 2 (GRB2), GRB2-related adaptor
protein 2 (GADS) and SLP adaptor and CSK-interacting
membrane protein (SLP76) as well as to the recruitment and
activation of phospholipase C (PLC) gamma 1 triggering Ca
2+ flux
along with the translocation of the transcription factor nuclear
factor of activated T-cells (NFAT) from the cytosol to the nucleus.
Furthermore, GRB2 and son of sevenless homolog (SOS) are also
involved in CD28 signaling leading to the activation of the
mitogen-activated protein kinase (MAPK) pathway and the
formation of the activator protein 1 (AP-1) complex resulting in
the production of IL-2 [39]. Given that tyrosine kinases Lck and
Fyn due to their relative low abundance were merely detectable by
immunostainings but not by silver staining [40] might explain their
missed detection in the current profiling study. In addition, it has
been demonstrated that LAT, a transmembrane protein, fails to
enter the isoelectrofocussing gel matrix and thus cannot be
detected by 2-DE-based expression profiling [40] thereby virtually
also excluding the detection of common T cell activation markers
such as as CD25 (IL-2 receptor), CD69 (activation inducer
molecule), CD71 (transferrin receptor) or HLA-DR (human
lymphocyte antigen class II cell surface receptor) for the same
reason. However, it provided the rational for the validation of
LAT by flow cytometry as an early activation marker. Moreover,
the PLC gamma 1-induced triggering of the Ca2+ flux was
validated by monitoring the expression pattern of CALM in
response to the various stimulation conditions (Figures 5 and 6),
taking further into account that it had been previously defined as
modified in response to CD28-mediated costimulation [36].
Furthermore, the molecular chaperone HSP7C was identified in
the context of T cell activation as a lipid raft-associated protein
[40] (Table S2), presumably supporting MAPK signaling, antigen
processing and presentation as well as endocytosis.
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partially activated T cells, is in line with previous studies on the
synthesis of leukocyte-derived growth factor in T lymphocytes
[41]. The protein is thought to be required for supplying the
secreted cleavage product CXCL7 in an autocrine fashion.
CXCL7 induces chemotaxis, supports the clustering of cells as
frequently observed for expanding T cells, and is also involved in
the induction of glucose uptake by inducing glucose transporter 1
(GLUT1) expression [42], thus supplying the activated cell with
energy resources. In addition, CXCL7 acts as a positive regulator
of cell growth displaying characteristics of a mitogene [41]. In line
with increased glucose uptake several enzymes associated with the
energy metabolism were found to be upregulated (Table S2).
These include in particular components of the glycolysis and
pentose phosphate pathways, such as ALDOA, ENOA, GAPDH,
LDHB and TKT, which previously had been identified as
Figure 5. Verification of differentially regulated proteins by flow cytometry. Isolated resting T cells were activated for 48 hrs with the
agonistic anti-CD3 antibody OKT3, anti-CD28 antibody 15E8 and IL-2. Incubation with non-activating isotype control mAbs were performed for
comparison. T cells were analyzed for the respective proteins by flow cytometry. Solid and dotted histograms represent staining with a specific
antibody and an isotype control antibody, respectively.
doi:10.1371/journal.pone.0032994.g005
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PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e32994Figure 6. Combined flow cytometric analysis of T cells from five healthy donors. The bar charts represent the mean of mean fluorescence
intensity (MFI) 6 standard error of mean (SEM) for the indicated target proteins. Statistical analyses were performed using an unpaired t-test.
doi:10.1371/journal.pone.0032994.g006
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addition PGK1, triosephosphate isomerase (TPIS) and TALDO,
were also defined as differentially expressed in response to distinct
costimulatory signals (Table S2). These data are in line with earlier
profiling results [36] thereby providing the rational for the
selection of GAPDH and LDH as representative validation targets
(Figures 5 and 6). In this context it is further noteworthy that some
isoforms of GAPDH, ALDOA and ENOA were also found to be
down-regulated in response to co-stimulatory signals, although the
nature for any of these isoforms has still to be defined.
The establishment of focal adhesions in response to TCR
activation as delineated from the current profiling results is in line
with the data reported by Nguyen and co-authors [43]. ACTN1
and TLN1 have been demonstrated to associate Ca
2+-dependent
with integrin alpha-L (LFA-1), which under physiological
conditions binds to intercellular adhesion molecule 1 (ICAM-1)
on APC, thereby initiating cell cell contact. ACTN1 was even
detected in several independent spots, including spots displaying
inverse regulation modes indicating that this protein might
undergo a series of post-translational modifications (PTM) in
response to the activating stimuli. Along with filamin-A (FLNA),
VINC (Table S2) and ACTB (Tables S1 and S3) these
differentially expressed proteins cover almost the entire focal
adhesion pathway.
In line with that, proteins involved in the organization of the
cytoskeleton are up-regulated, alike the tropomyosin 1 alpha chain
(TPM1) (Table S2), which is involved in the movement of cellular
components and the regulation of cell migration or myosin-9
(MYH9), which is involved in important cellular processes like the
establishment of T cell polarity, cell morphogenesis involved in
differentiation as well as in the organization of the mitotic spindle.
Concomitantly, GELS that is linked to the disassembly of cellular
components and the depolymerization of actin filaments was
found to be down-regulated (Table S2). Furthermore, the up-
regulated syntaxin-binding protein 2 (STXB2), a protein linked to
vesicle-mediated transport, supports the finding that a consider-
able number of the differentially expressed proteins seem to be
involved in modulating the extracellular compartment.
Further evidence that T cell activation is associated with
dynamic changes of the actin cytoskeleton comes from a recent
report of Lin and co-workers [44] analyzing the composition of
lipid raft proteins in response to chemokine stimulation in Jurkat
cells thereby demonstrating that the molecular chaperone heat
shock protein HSP 90-alpha (HS90A) not only acts as scaffolding
site in lipid rafts, but also appears to be involved in stimulating/
mediating Ca
2+ flux and in the regulation of the structure of actin
filaments assembled by neuronal Wiskott-Aldrich Syndrome
protein (N-WASP) and the Arp2/3 complex thereby activating
the small GTPases Rac and Rho, which can both be linked to
mediate cell migration. The observed up-regulation of HS90A in
response to costimulatory signals (Table S2) suggests a similar role
for HS90A in the context of this type of T cell activation.
Furthermore, other proteins involved in the rearrangement of the
actin cytoskeleton, like CALM, ARPC2, CAZA1, PROF1 and
PLSL are actively recruited into lipid rafts [44] and exert a similar
regulation pattern in response to activation of T cells by
costimulatory signals. The Ca
2+-mediated up-regulation of CALM
and PLSL (Table S2) in combination with the down-regulation of
PROF1 strongly support the reorganization of the actin
cytoskeleton and the favoring of actin polymerization, dispite the
fact that ARPC2 was found to be down-regulated, which however
might be compensated by the up-regulation of CAZA2 (Table S2).
Moreover, these results are also in line with the phosphoproteomic
profiling data presented by Nguyen and co-workers [43] revealing
that CALM, GDIR2 and LAT are differentially expressed during
T cell activation, leading to the selection of these representative
proteins to the group of validated targets (Figures 5 and 6).
Concerning the expression pattern of proteins associated with
signal transduction pathways, the up-regulation of ILK, which
together with LIM and senescent cell antigen-like containing
domain protein 1 (LIMS1), is up-regulated in CD28-stimulated
T cells acts as a receptor proximal protein kinase and regulates
integrin-mediated signal pathways, such as the formation of focal
adhesions. However, another isoform of ILK is consistently down-
regulated. PDIA3 has isomerase activity, interferes with signaling
pathways, is a potential positive regulator of apoptosis and is up-
regulated under certain costimulation conditions. Moreover, the
down-regulation of GDIR2, a regulator of small GTPase-
mediated signal transduction pathways and a negative regulator
of cell adhesion is in accordance to the T cell activation process as
is the down-regulation of the functionally related Rab GDP
dissociation inhibitor alpha (GDIA) that is reacting to calcium
influx (Table S2).
Recent profiling data addressing the altered protein expression
pattern in T cells following phytohemagglutinin (PHA) stimulation
defined a panel of differentially expressed proteins [37]. Based on
the current profiling approximately 50% thereof are also
modulated in response to costimulation-mediated T cell activation.
The overlap amongst the groups of down-regulated proteins is
higher (60%) than for the group of up-regulated proteins (35%).
For instance, ACTN1, GAPDH, HSP7C, PDIA3, SODM, TBB5
and VINC, within the groups of down-regulated proteins or
PGK1 and ALDOA representing examples for up-regulated
proteins. In addition, ACTN1, ALDOA, GAPDH, VINC and
TLN1 were also represented by several independent spots, likely
due to undergoing PTM (Table S1, Table S2 and Table S3).
Unexpectedly, none of the up-regulated isoforms of GAPDH
reached the required threshold levels (factor: .2 silver staining;
.1.5, DIGE). However, taking into account that GAPDH is prone
to undergo massive PTM (Figure 2) it is likely that not all of its
variants were identified. Though at least the PTM-independent
flow cytometric stainings (Figure 5 and 6) confirm the induction of
GAPDH at the total protein expression level in response to the
different stimulation.
Furthermore, the data presented by Sheng and Wang [37]
suggest that GAPDH might play a role as transcriptional regulator
during T cell activation since it is co-immunoprecipitated in ChiP
assays. In addition to its central function in glycolysis, there is
increasing evidence, that GAPDH is also linked to DNA repair,
tRNA export, membrane fusion and transport, cytoskeletal
dynamics as well as cell death [45]. The diverse functions of
GAPDH are dependent on its grade of oligomerization,
posttranslational modifications and its cellular localization. Under
normoxic conditions GAPDH is predominantly expressed in the
cytosol, functioning as a housekeeping protein in the glycolysis by
forming a tetramer. Under oxidative stress GAPDH can undergo
S-thiolyation, leading to a metabolic shift towards the pentose
phosphate pathway. In addition the redox-sensitive cysteine
residue of GAPDH binds to inositol 1,4,5-trisphosphate receptors
in close proximity to calcium channels of the ER membrane,
thereby regulating Ca2+-mediated signaling [46]. Thus, the up-
regulation of CALM in response to CD3/CD28 and CD3/IL2
mediated T cell activation may be linked to the increased GAPDH
expression levels.
Taking further into account that GAPDH can also interact with
tubulins and actins [47,48] the differential expression of various
tubulins (tubulin alpha-1A chain (TBA1A), tubulin alpha-1B chain
(TBA1B), tubulin alpha-1C chain (TBA1C), tubulin alpha-4A
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as of isoforms of ACTB and/or ACTG are plausible (Table S2).
The binding of GAPDH to microtubules leads to a reduction of its
glycolytic activity due to the dissociation of its metabolic active
tetrameric structure into inactive monomers [49]. In addition,
enzymatically active GAPDH can be transported within the cell
via the microtubule treadmill. In particular phosphorylated
isoforms of GAPDH are involved in mediating vesicular trafficking
between cellular compartments, such as between the ER and the
Golgi apparatus, by acting as an adaptor or scaffolding protein
[50]. This role of GAPDH may be relevant during T cell
activation given the fact that differentially expressed proteins
including signaling molecules like CXCL7 or PDIA1 as well as
structural molecules, like ACTN1, GELS, VINC, TLN1 along
with the anti-oxidants THIO next to several others can reach the
extracellular region under physiological conditions (Figure 4).
Although under stress conditions GAPDH is predominantly S-
nitrosylated, interacts with Siah, an E3 ubiquitin-protein ligase
[51] and is then translocated to the nucleus leading to cellular
dysfunction and cell death, it can also be translocated into the
nucleus without induction of cell death likely post undergoing O-
GlcNAcylation in the cytosol [52] via an as yet undisclosed
mechanism. Subsequently GAPDH can bind to protein SET,
increasing mitosis by acceleration of the cell cycle, due to higher
cyclin B-cdk1 activity [53]. Taken together, posttranslational
modifications of GAPDH reflect the various activation-associated
alterations in transport, metabolism and signaling of activated
T cells.
Nyman and colleagues [54] reported a 2-DE-based map of
CD3/CD28-stimulated CD4
+ helper cells providing the identifi-
cation of 91 spots representing 72 proteins. Fourteen of the
identified proteins were represented by more than one spot
implying posttranslational modifications; however, none of the
identified proteins was linked to cellular processes. However, based
on the current report, 15 of these proteins can now be associated
with cellular processes linked to T cell activation, namely
mitochondrial stress-70 protein 70 (GRP75), HSP7C, 78 kDa
glucose-regulated protein (GRP78), PDIA3, ENOA, ATPD,
PGK1, ACTB, TPIS, GRB2, GDIR1, GDIR2, ATP synthase
subunit d (ATP5H) and PROF1.
From the overall 30 proteins that previously had also been
identified as differentially expressed in plasma membrane
proximal domains during T cell activation [38] 8/11 defined as
up-regulated maintained their regulation mode, including the
metabolic enzymes ENOA and LDHB, the cytoskeleton compo-
nents TBB5, MYH9, PROF1, TLN1 and PLSL as well as the
stress protein HSP90A (Table S2). In contrast, GAPDH and the
signaling components GBR2 and GDIR2 defined as up-regulated
in membrane-proximal domains upon T cell activation were
rather defined as down-regulated in this 2-DE-based profiling
report (Table S2), which at least for GDIR2 was confirmed
(Figures 5 and 6). Nonetheless, this still does not rule out its
enrichment in receptor-proximal membrane domains. For some of
these targets, like PROF1, TBB5, ENOA, TLN1 and HSP90A
also counter-regulated spots were detected. However, since these
proteins can undergo PTMs, this is not unexpected and represents
an advantage of the gel-based versus the corresponding peptide-
based SILAC approach.
Within the group of targets that was previously classified as
down-regulated, 8/13 of the shared proteins maintained their
regulation mode, including the metabolic enzymes ATP5B,
ATP5H, PDIA1 and PDIA3, the cytoskeleton components
ARPC2 and FLNA as well as ALBU and CALR (Table S2). A
partial counterregulation was detected for ATPB and PDIA3,
whereas the cytoskeleton components ARP3, and CAZA2, the
signaling component CALM next to GRP78 and STXB2 exerted
a general counterregulation. However, the inverse regulation
identified for CALM (Table S2) is again supported by the
validation data (Figures 5 and 6).
Moreover, for the metabolic enzymes ALDOA, PGK1 and
SODM, the cytoskeleton components ACTN1 and tropomyosin
alpha-3 chain (TPM3) as well as for hemoglobin subunit beta
(HBB) the current profiling now defines the respective regulation
pattern (Table S2). The role of ALDOA appears to depend on
certain PTM since both up-regulated and down-regulated
ALDOA spots could be detected, in particular in partially
activated T cells. An inverse regulation pattern were also defined
for ACTN1, which seems to be up-regulated in partially
stimulated, but down-regulated in fully activated T cells. For
PGK1 the up-regulation is in line with the concept that stimulated
T cells require higher energy levels. In contrast, SODM is down-
regulated under all stimulation conditions, in line with the report
by Kronfeld and colleagues [36]. TPM3, previously defined as
phosphorylated in response to costimulation [36] is down-
regulated, in at least CD3 + IL2-stimulated T cells, whereas
HBB defined as up-regulated in CD28-stimulated T cells seems to
be rather inversely regulated based on the current profiling data.
However, the function of both proteins during T cell activation
still needs to be defined.
This is also the case for a subset of differentially expressed
proteins that has not yet been linked to the costimulation-mediated
T cell activation process..From the group of metabolic enzymes
UGPA is likely involved in the metabolism of sugars, whereas
TPIS, TALDO and TKT represent components of the glycolysis
and pentose phosphate pathways, respectively (Table S2).
Analogous to SODM THIO is involved in counteracting the
increase of reactive oxygen species during T cell activation as
previously described for murine T cells by Michalek and
coworkers [55]. The proteasomal subunit PSB4, previously also
defined as phosphorylated in response to costimulation [36] is
likely contributing to the ubiquitin-mediated proteolysis of cell
surface and signaling molecules in response to the activation of the
TCR signaling pathway [38]. From the group of components of
the cytoskeleton, VINC is bridging the gap in the focal adhesion
pathway between ACTN1, FLNA and TLN1 and the initiation of
actin polymerization, while GELS and TBA8 are involved in the
reorganization of the actin cytoskeleton. The signaling compo-
nents GDIR1 and GDIR2 are both considered as regulators of
small GTPase- and Rho protein-mediated signal transduction
processes, whereas the functions of the down-regulated targets
annexin A 5 (ANXA5), chloride intracellular channel protein 1
(CLIC1) and GDIA (Table S2) in the process of T cell activation
still have to be elucidated.
This also holds up for proteins that could not be categorized
into the 3 main groups (Table S2), in particular for the secreted
proteins fibrinogen beta chain (FIBB), fibrinogen gamma chain
FIBG and the membrane–associated integrin alpha IIb (ITA2B),
wheras for SH3 domain-binding glutamic acid-rich-like protein 3
(SH3L3) a function towards (re-)establishing redox homeostasis
seems likely.
Taken together the profiling data presented in this report
provide novel insights into the complex alterations of the proteome
during T cell activation, in particular in regard to alterations in the
metabolism, the reorganization of the cytoskeleton and the
initiation/modulation of signaling pathways. Thus, the profiling
results increase the knowledge with respect to the network of
underlying biological processes associated with the activation of
T cells beyond the individual signal transduction pathways.
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Isolation of T Cells
CD3
+ T cells were isolated from the peripheral blood of healthy
human donors. In brief, mononuclear cells (PBMC) were isolated
by Ficoll-Paque gradient centrifugation (Amersham Biosciences,
Amersham, UK), CD3
+ T cells purified by negative selection with
the ‘‘MACS human pan T cell isolation kit’’ using the AutoMACS
Pro separator (Miltenyi Biotech, Bergisch Gladbach, Germany).
T cell purity was routinely .98% as determined by flow
cytometry (FACS Canto, BD Biosciences, Heidelberg, Germany).
Cells were cultured in X-Vivo15 medium containing 10% (v/v)
fetal calf serum (FCS), 1% (v/v) Penicillin/Streptomycin (100 X;
10.000 U/ml/10 mg/ml) and 2 mM glutamine (all purchased
from Sigma Aldrich, Deisenhofen, Germany).
T Cell Activation
Polysorb culture plates (Nunc, Roskilde, Denmark) were coated
with the anti-CD3 antibody OKT3 (Natutec, Frankfurt/Main,
Germany, 10 mg/ml coating concentration), the anti-CD28
antibody 15E8 (CLB, Amsterdam, Netherlands, 10 mg/ml), both
OKT3 and 15E8 antibodies (each 10 mg/ml), and OKT3
antibody (10 mg/ml) and IL-2 (Endogen, Woburn, MA, USA,
1000 U/ml. Plates coated with an isotype matched IgG antibody
(10 mg/ml) served as controls. Isolated CD3
+ T cells were cultured
in coated plates in complete X-Vivo15 medium (Lonza, Cologne,
Germany) for 48 hrs.
Two-dimensional Gel Electrophoresis (2-DE) and
Difference Gel Electrophoresis (DIGE)
Isolated CD3
+ T cells after antibody stimulation or incubation
with an isotype-matiched IgG antibody as control were initially
subjected to 2-DE-based expression profilings by loading 150 mg
protein per sample. Proteins were visualized by silver stainings as
previously described [56]. In addition, quantitave profilings were
performed by applying an DIGE approach based on a minimal
labeling strategy according to the manufacturer’s instruction
(Amersham Biosciences, Freiburg, Germany). For minimal label-
ings, 15 mg protein representing a mixture of equal amounts of
total lysates derived from stimulated (OKT3, 15E8, OKT3 plus
IL2, OKT3 and 15E8) and non-stimulated (IgG isotype) CD3
+
T cells were labeled with CyDye DIGE fluor 2 as internal protein
standard (IPS). In parallel 15 mg total protein lysates from either
stimulated or non-stimulated CD3
+ T cells were separately labeled
with CyDye DIGE fluors 3 and 5, respectively. Each labeling
reaction was performed in a total volume of 20 ml DIGE lysis
buffer (30 mM Tris, 7 M urea (Applichem, Darmstadt, Germany),
2 M thiourea (Sigma, Deisenhofen, Germany) 4% (w/v) CHAPS
(Applichem), adjusted to pH 8.5) after adding 100 pmol CyDye
(Amersham Biosciences) dissolved in 1 ml dimethylformamide for
30 minutes on ice. The labeling reaction was stopped by adding
1 ml 10 mM lysine (Merck Biosciences GmbH, Schwalbach,
Germany) followed by 10 minutes on ice. Isoelectric focusing
using Immobiline DryStrips pH 3–10 NL (Amersham Biosciences)
and second dimension SDS separation were performed as
previously described [56]. Gels were washed three times in
destilled water and thereafter scanned using a Fuji FLA 5100
fluorescence scanner (Fuji Photo Film GmbH, Du ¨sseldorf,
Germany) equipped with 3 lasers. Cy2 images were acquired
with a blue laser (473 nm) in combination with a LPB filter
(510 nm), whereas Cy3 and Cy5 with green (532 nm) and red
lasers (635 nm) in combination with LPG (575 nm) and LPR (665)
filters, respectively. For all scannings the voltage applied to the
photomultiplier tubes (PMT) was set to 50 V below the saturation
level of the most abundant protein spot within the given gel
(ranging from 600–800 V). All gel images were recorded at a
resolution of 100 mm.
Image Analysis
Quantitative image analyses of 2-DE gels were performed using
either the Proteomweaver (Version 4.0, Bio-Rad GmbH, Munich,
Germany) or for DIGE gels the Delta2D (Version 4.2, Decodon
GmbH, Greifswald, Germany, DIGE) software packages accord-
ing to the manufacturer’s guidelines. Spots displaying upon
stimulation either a relative up- or down-regulation ratio of factor
$2.0 (silver staining) or .1.5 (DIGE) compared to the respective
control were classified as differentially expressed and selected for
subsequent micro-analytical characterization.
Mass Spectrometry and Data Mining
Preparative gels were loaded with 750 mg total protein of cell
lysates, the spots of interest were subsequently digested in the
respective gel in situ and subjected to mass spectrometry using the
matrix-assisted laser-desorption/ionization time of flight (MALDI-
TOF) instrument Voyager DE
TM PRO (Applied Biosystems,
Forster City, CA, USA) as previously described [57]. However,
due to the very limited sample material available, preparative gels
were run with samples representing unfractionated Ficoll-isolated
T cells obtained from healthy donors. Therefore, the analysis was
only restricted to those spots, which could be matched between the
profiles of the crude and highly purified T cell preparations.
Database searches were performed using the MASCOT software
package (Matrix Science, London, UK). Data obtained from free
accessible data banks were analyzed with an in-house web-based
tool and linked to a mySQL database (db) as recently described
[58]. The data sets of the identified genes and proteins were linked
to the Swiss-Prot identities (UniProt Knowledgebase Release
2011_05).
Flow Cytometry
T cells were washed twice in 2 ml FACSFlow (BD Biosciences,
Heidelberg, Germany) containing 0.1% (w/v) bovine serum
albumin (Sigma Aldrich) and resuspended to a concentration of
20610
6 per ml. Cells were fixed and permeabilized using the
‘‘INTRASure kit’’ (BD Biosciences). Washed cells were incubated
with 10 ml each of titrated antibody directed against LAT (BD
Biosciences), CALM (Abcam, Oxford, UK), GAPDH (Cell
Signaling, Frankfurt/Main, Germany), LDH (Abcam), GDIR2
(Lifespan Biosciences, Seattle, USA) or CXCL-7 (Santa Cruz
Biotech, Heidelberg, Germany), respectively, for 20 min at 4uCi n
the dark, washed and 1 mg/tube of fluorochrome-conjugated
secondary antibody was added for 20 min at 4uC. As control an
isotype-matched IgG was used as primary antibody. Cells were
fixed with 1% (w/v) PFA (Sigma Aldrich) and analysed, on a
‘‘FACSCanto III’’ flow cytometer. Data were analysed using
FACSDiva software (BD Biosciences) with a minimum of 10,000
events. Live cells were recorded prior the fixation step utilizing 7-
AAD.
Supporting Information
Table S1 List of differentially expressed proteins defined by
silver staining (regulation factor .2).
(PDF)
Table S2 List of differentially expressed proteins classified
according to their cellular function.
(PDF)
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